Eledon Pharmaceuticals (ELDN) Other Working Capital Changes (2019 - 2026)
Eledon Pharmaceuticals (ELDN) posted Other Working Capital Changes of -$86000.0 for Q1 2026, down 6.17% on a QoQ basis from -$81000.0 in Q4 2025, and down 16.22% year-over-year from -$102645.2 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$86000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 16.22% year-over-year to -$86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$325000.0 (down 3.5% YoY) and the FY2025 annual result came in at -$313000.0, up 7.67% from the prior year.
- Other Working Capital Changes was -$86000.0 for Q1 2026 at Eledon Pharmaceuticals, down from -$81000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.6 million in Q4 2023 and bottomed at -$1.4 million in Q2 2024.
- A 5-year average of -$73588.2 and a median of -$338000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 97.83% — and 2024, when it advanced 28.72%.
- Eledon Pharmaceuticals' Other Working Capital Changes stood at -$93000.0 in 2022, then fell by 3.23% to -$96000.0 in 2023, then grew by 6.25% to -$90000.0 in 2024, then increased by 10.0% to -$81000.0 in 2025, then slipped by 6.17% to -$86000.0 in 2026.
- Business Quant data shows ELDN's Other Working Capital Changes at -$86000.0 in Q1 2026, -$81000.0 in Q4 2025, and -$81000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Eledon Pharmaceuticals | 399.11 Mn | 399.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86,000.00 |
| Mar 31, 2026 | -86,000.00 |
| Mar 31, 2026 | -86,000.00 |
| Dec 31, 2025 | -81,000.00 |
| Dec 31, 2025 | -81,000.00 |
| Dec 31, 2025 | -81,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -77,000.00 |
| Jun 30, 2025 | -77,000.00 |
| Jun 30, 2025 | -77,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Mar 31, 2025 | -74,000.00 |
| Dec 31, 2024 | -90,000.00 |
| Dec 31, 2024 | -90,000.00 |
| Dec 31, 2024 | -90,000.00 |
| Sep 30, 2024 | -83,000.00 |
| Sep 30, 2024 | -83,000.00 |